Here are latest updats and news about our company.
Publications
Regulation (EU) 2017/745- clinical trials application process
After almost 25 years, the law on…
Clinmark
November 30, 2022
Publications
Medical Device Q&A MDCG 2021-6 / Regulation (EU) 2017/745 (Part 3)
What is considered burdensome or…
Clinmark
October 31, 2022
Publications
Medical Device Q&A MDCG 2021-6 / Regulation (EU) 2017/745 (Part 2)
Which regulatory pathway should a…
Clinmark
September 9, 2022
Publications
Questions & Answers – MDCG 2021-6 / Regulation (EU) 2017/745 (Part 1)
What are the general differences and…
Clinmark
July 20, 2022
Publications
Clinical trials – Why are they so expensive?
It’s a pretty common knowledge that…
Clinmark
March 25, 2022
Publications
Clinical Trials Information System
On July 31, 2021, the European…
Clinmark
March 11, 2022
Publications
The importance of collaboration of operational and pharmacovigilance team
Latin “vigilare” – to keep awake or…
Clinmark
March 4, 2022
Publications
Transparency of clinical trials and its influence on the documentation under the Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use
One of the objectives of the Regulation…
Clinmark
February 18, 2022
Publications
MALARIA VACCINE DEVELOPMENT – CLINMARK’s CEO PARTICIPATION
More than 130 years after discovering…
Clinmark
February 4, 2022
Publications
Authorization to conduct clinical trials in accordance with the Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use
The process of obtaining authorization…
Clinmark
January 28, 2022
Publications
Decentralized Clinical Trials (DCT) – are clinical trials evolving into virtual clinical sites?
The discussion about future vision of…
Clinmark
January 21, 2022
Publications
Final countdown to entry into force of the Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use
We are only days away from the entry…
Clinmark
January 10, 2022
Publications
8 things to consider when conducting clinical trial during coronavirus pandemic
Conduct of clinical trials is related…
Clinmark
April 29, 2020
Publications
Top quality in clinical trials
Why QUALITY matters in the clinical…
Clinmark
August 30, 2019
Publications
Supporting our innovation
How to make a smartphone to control the…
Clinmark
July 30, 2019
Here are latest updats and news about our company.
Regulation (EU) 2017/745- clinical trials application process
After almost 25 years, the law on…
Medical Device Q&A MDCG 2021-6 / Regulation (EU) 2017/745 (Part 3)
What is considered burdensome or…
Medical Device Q&A MDCG 2021-6 / Regulation (EU) 2017/745 (Part 2)
Which regulatory pathway should a…
Questions & Answers – MDCG 2021-6 / Regulation (EU) 2017/745 (Part 1)
What are the general differences and…
The importance of collaboration of operational and pharmacovigilance team
Latin “vigilare” – to keep awake or…
Transparency of clinical trials and its influence on the documentation under the Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use
One of the objectives of the Regulation…
MALARIA VACCINE DEVELOPMENT – CLINMARK’s CEO PARTICIPATION
More than 130 years after discovering…
Authorization to conduct clinical trials in accordance with the Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use
The process of obtaining authorization…
Decentralized Clinical Trials (DCT) – are clinical trials evolving into virtual clinical sites?
The discussion about future vision of…
Final countdown to entry into force of the Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use
We are only days away from the entry…
8 things to consider when conducting clinical trial during coronavirus pandemic
Conduct of clinical trials is related…